Lazard Asset Management’s Provident Financial Services PFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$787K Buy
33,278
+6,194
+23% +$139K ﹤0.01% 1290
2026
Q1
$573K Buy
27,084
+1,547
+6% +$33K ﹤0.01% 1334
2025
Q4
$504K Buy
25,537
+75
+0.3% +$1.45K ﹤0.01% 1373
2025
Q3
$491K Buy
+25,462
New +$486K ﹤0.01% 1354
2023
Q2
Sell
-1,356
Closed -$26K 2478
2023
Q1
$26K Sell
1,356
-95,580
-99% -$2.11M ﹤0.01% 1989
2022
Q4
$2.07M Sell
96,936
-6,009
-6% -$129K ﹤0.01% 902
2022
Q3
$2.01M Sell
102,945
-4,481
-4% -$105K ﹤0.01% 884
2022
Q2
$2.39M Buy
107,426
+91,418
+571% +$2.04M ﹤0.01% 865
2022
Q1
$374K Buy
+16,008
New +$385K ﹤0.01% 1150
2019
Q2
Sell
-50,667
Closed -$1.31M 1237
2019
Q1
$1.31M Buy
+50,667
New +$1.33M ﹤0.01% 809

Other funds holding PFS

Lazard Asset Management's PFS Position: Q2 2026 in Review

Lazard Asset Management increased its Provident Financial Services (PFS) stake by 23% in Q2 2026, buying an estimated $139K and bringing the position to 33,278 shares worth $787K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Lazard Asset Management first reported a position in PFS in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.39M in Q2 2022. 315 funds tracked by Wall St. Rank hold PFS as of Q2 2026.

  • Lazard Asset Management held 33,278 shares of Provident Financial Services worth $787K as of Q2 2026.
  • Lazard Asset Management bought 6,194 Provident Financial Services shares in Q2 2026, an estimated $139K.
  • Provident Financial Services made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1290 holding.
  • Lazard Asset Management first reported a position in Provident Financial Services in Q1 2019 and has held it in 10 quarters since.
  • Lazard Asset Management's Provident Financial Services position peaked at $2.39M in Q2 2022.
  • 315 funds tracked by Wall St. Rank held Provident Financial Services as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.